A detailed history of Guardian Wealth Advisors, LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Guardian Wealth Advisors, LLC holds 8,013 shares of ABBV stock, worth $1.52 Million. This represents 0.18% of its overall portfolio holdings.

Number of Shares
8,013
Previous 8,047 0.42%
Holding current value
$1.52 Million
Previous $1.47 Million 6.21%
% of portfolio
0.18%
Previous 0.2%

Shares

11 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

SELL
$154.79 - $180.76 $5,262 - $6,145
-34 Reduced 0.42%
8,013 $1.37 Million
Q1 2024

May 15, 2024

BUY
$159.82 - $182.1 $38,196 - $43,521
239 Added 3.06%
8,047 $1.47 Million
Q4 2023

Feb 14, 2024

SELL
$137.6 - $154.97 $59,580 - $67,102
-433 Reduced 5.25%
7,808 $1.21 Million
Q3 2023

Nov 14, 2023

BUY
$133.59 - $154.65 $6,679 - $7,732
50 Added 0.61%
8,241 $1.23 Million
Q2 2023

Aug 14, 2023

BUY
$132.51 - $164.9 $50,221 - $62,497
379 Added 4.85%
8,191 $1.1 Million
Q1 2023

May 15, 2023

BUY
$144.61 - $166.54 $193,343 - $222,663
1,337 Added 20.65%
7,812 $1.24 Million
Q4 2022

Feb 14, 2023

BUY
$138.31 - $165.87 $829 - $995
6 Added 0.09%
6,475 $1.05 Million
Q3 2022

Nov 14, 2022

SELL
$134.21 - $153.93 $110,857 - $127,146
-826 Reduced 11.32%
6,469 $868,000
Q2 2022

Aug 15, 2022

BUY
$137.62 - $174.96 $243,312 - $309,329
1,768 Added 31.99%
7,295 $1.12 Million
Q1 2022

May 16, 2022

SELL
$131.98 - $163.75 $22,040 - $27,346
-167 Reduced 2.93%
5,527 $896,000
Q4 2021

May 16, 2022

BUY
$107.43 - $135.93 $611,706 - $773,985
5,694 New
5,694 $771,000

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $335B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Guardian Wealth Advisors, LLC Portfolio

Follow Guardian Wealth Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Guardian Wealth Advisors, LLC , based on Form 13F filings with the SEC.

News

Stay updated on Guardian Wealth Advisors, LLC with notifications on news.